MAP2K1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.811200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.582400E-01
Normal-vs-Stage2
9.725200E-01
Normal-vs-Stage3
1.597390E-01
Normal-vs-Stage4
6.576200E-01
Stage1-vs-Stage2
6.070000E-01
Stage1-vs-Stage3
1.797160E-01
Stage1-vs-Stage4
9.499800E-01
Stage2-vs-Stage3
8.426000E-02
Stage2-vs-Stage4
6.328400E-01
Stage3-vs-Stage4
3.435400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.841600E-01
Normal-vs-AfricanAmerican
9.517600E-01
Normal-vs-Asian
5.276000E-01
Caucasian-vs-AfricanAmerican
7.572800E-01
Caucasian-vs-Asian
2.468800E-01
AfricanAmerican-vs-Asian
4.122600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.389600E-01
Normal-vs-Female
9.496800E-01
Male-vs-Female
5.657200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.997800E-01
Normal-vs-Age(41-60Yrs)
6.765600E-01
Normal-vs-Age(61-80Yrs)
7.087000E-01
Normal-vs-Age(81-100Yrs)
4.560600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.258200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.279800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.445400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.678100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.723900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.802800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.005000E-01
Normal-vs-Daily Drinker
5.239400E-01
Normal-vs-Weekly Drinker
7.712400E-01
Normal-vs-Occasional Drinker
9.391200E-01
Normal-vs-Social Drinker
5.786000E-01
Non Drinker-vs-Daily Drinker
7.184400E-01
Non Drinker-vs-Weekly Drinker
8.111200E-01
Non Drinker-vs-Occasional Drinker
2.559400E-01
Non Drinker-vs-Social Drinker
9.561000E-01
Daily Drinker-vs-Weekly Drinker
6.327000E-01
Daily Drinker-vs-Occasional Drinker
1.915350E-01
Daily Drinker-vs-Social Drinker
7.164800E-01
Weekly Drinker-vs-Occasional Drinker
5.206800E-01
Weekly Drinker-vs-Social Drinker
8.654400E-01
Occasional Drinker-vs-Social Drinker
3.401200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.509400E-01
Normal-vs-Grade 2
7.550400E-01
Normal-vs-Grade 3
7.674800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.944200E-02
Grade 1-vs-Grade 3
2.082800E-01
Grade 1-vs-Grade 4
8.509400E-01
Grade 2-vs-Grade 3
7.806800E-01
Grade 2-vs-Grade 4
7.550400E-01
Grade 3-vs-Grade 4
7.674800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.593400E-01
Normal-vs-NonDiabetic
8.732000E-01
Diabetic-vs-NonDiabetic
2.187200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.879800E-01
Normal-vs-NoPancreatitis
7.930400E-01
Pancreatitis-vs-NoPancreatitis
6.260200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.285200E-01
Normal-vs-N1
9.942400E-01
N0-vs-N1
1.554610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.791800E-01
Normal-vs-TP53-NonMutant
3.087400E-01
TP53-Mutant-vs-TP53-NonMutant
3.943100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
